Your SlideShare is downloading. ×
Daily equity-report by epic research 18 april 2013
Daily equity-report by epic research 18 april 2013
Daily equity-report by epic research 18 april 2013
Daily equity-report by epic research 18 april 2013
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Daily equity-report by epic research 18 april 2013

42

Published on

Published in: Economy & Finance, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
42
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. HEADLINES -=6  Indian Market  Indian equity markets were down 0.25%  Nifty down by 0.25 pts and settle at 5688.70  Sensex down by 9.76 pts at 18735.17  Bank Nifty up by 116.80 pts at 11988.40  Global Market DAILY EQUITY  European markets were down with FTSE NEWSLETTER down by 31.13 closed at 6273 ,CAC down by 35.83 closed at 3649 and DAX down 18TH APRIL 2013 95.94 closed at 7586 Dow future was up by 56 closed at 14629.00  HEADLINES• HCL Tech beats street; Q3 net jumps73% YoY to Rs 1,040cr• Yes Bank Q4 net soars 33% to Rs 362cr• India likely to grow by 5.7% in2013:WEO• SAILs value added steel production up4% at 5 MT in FY13 WWW.EPICRESEARCH.CO 09752199966
  • 2.  MARKET ANALYSIS:  Key benchmark indices closed flat after witnessing high intraday volatility. The Sensex lost 13.77 points or 0.07%, off close to 140 points from the days high and up about 60 points from the days low. The market breadth, indicating the overall health of the market, turned negative from positive in late trade. Index heavyweight Reliance Industries (RIL) dropped after the company reported muted sequential growth in net profit in Q4 March 2013 after trading hours on Tuesday, 16 April 2013. Another index heavyweight and cigarette major ITC hit record high..  Indian stocks snapped two day winning streak today, 17 April 2013. The Sensex had gained 502.37 points or 2.75% in two trading sessions to settle at 16744.93 on Tuesday, 16 April 2013, from a recent low of 18242.56 on 12 April 2013. The Sensex has fallen 104.61 points or 0.55% in this month so far (till 17 April 2013). The Sensex has declined 695.55 points or 3.58% in calendar 2013 so far (till 17 April 2013). From a 52-week high of 20,203.66 on 29 January 2013, the Sensex has declined 1,472.50 points or 7.28%. From a 52-week low of 15,748.98 on 4 June 2012, the Sensex has surged 2,982.18 points or 18.93%  Coming back to todays trade, IT stocks fell on firm rupee. Software major Tata Consultancy Services (TCS) dropped ahead of its Q4 results today, 17 April 2013. HCL Technologies reversed direction after hitting a record high after the company reported good Q3 results. S&P BSE Sensex lost 13.77 points or 0.07% to 18,731.16, its lowest closing level since 15 April 2013. STOCKS TO WATCH  FII’s and DII’s  HCLCATEGORY DATE BUY SELL NET  INFOSYS FII 17-Apr-13 3714.78 3508.1 206.68  ITC  SUN PHARMA DII 17-Apr-13 1043.55 1304.48 -260.93 SCRIPS IN BAN PERIOD  NIFTY DAILY PIVOTS  HDILPIVOT R4 R3 R2 R1 PP S1 S2 S3 S4NIFTY 5885 5822 5759 5723 5696 5660 5633 5570 5507 WWW.EPICRESEARCH.CO 09752199966
  • 3. .  GAINERS AND LOOSERS EXPERT OPINION NIFTY DAILY NIFTY GAINERS  Nifty looks BearishSCRIPS RATE VOL. PR. NET %  Strategy: Sell on rise (000) CLOSE CHAN CHANG GE E  Support: 5630 M&M 880.90 2993.24 844.85 36.05 4.27  Resistance: 5730 Sesa BANK NIFTY 149.25 3049.85 143.40 5.85 4.08 Goa  Bank Nifty looks Bearish Ambuja 187.05 3414.65 180.45 6.60 3.66Cement  Strategy: Sell on rise SBI 2245.15 2463.76 2183.10 62.05 2.84  Support: 11900 Sun 914.25 1392.93 889.40 24.85 2.79  Resistance: 12500Pharma 460  PREVIOUS PERFORMANCE .0 DAILY NIFTY LOOSERS TYPE SCRIP B/S RESULTSCRIPS RATE VOL. PR. NET % (000) CLOSE CHAN CHAN AUROBINDO CASH B TGT HIT PHARMA GE GE KARNATAK Reliance CASH B TGT HIT BANK 773.7 7337.41 804.95 -31.25 -3.88Industries ALLAHBAD Reliance FUTURE B TGT HIT BANK 357.15 3685.5 367.15 -10 -2.72 Infra FUTURE ITC B TGT HIT TCS 1456.65 2637.42 1483.15 -26.5 -1.79 Tata 94.55 1862.98 96.15 -1.6 -1.66 Power HDFC 790.4 3284.07 803.7 -13.3 -1.65 WWW.EPICRESEARCH.CO 09752199966
  • 4. MARKET CALLS 6 CASH SCRIPS ACTION LEVEL 1ST TARGET 2ND TARGET STOP LOSS AUROBINDO BUY 185.00 186.00 187.00 184.00 PHARMA REC SELL 218.00 216.00 214.00 220.00 FUTURE ST ND SCRIPS ACTION LEVEL 1 TARGET 2 TARGET STOP LOSS. ALLAHBAD BANK BUY 136.50 137.50 138.50 135.50 ANDHRA BANK SELL 91.00 80.50 80.00 91.50 Disclaimer The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE. The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer. All Rights Reserved. Investment in equity & bullion market has its own risks. We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.

×